Rachel Reeves wants to encourage a shift – but negative headlines about the risks could be making British consumers wary.

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...

Shares of Johnson & Johnson climbed 4.5% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for the biggest one-day gain since they rallied 4.6% on May 1, 2024.

Tariff revenues surged to $24.2 billion in May—an all-time high since World War II, according to the U.S. Treasury Department—contributing to inflationary pressure on U.S. consumers.

President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Economists say it will take time for the effects of trade policies to show up in economic data — but acknowledge they aren’t ...

Johnson & Johnson rose 1.8% after the drug and medical device giant beat analysts' sales and profit targets and raised its ...

Tariffs are now feeding through to consumer prices, pushing inflation higher and disrupting the prior disinflationary trend.

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports while monitoring ever-changing developments on U.S. trade policy. Futures ...

Rivian stock has trended upward recently despite facing challenges. Here is a look at where the stock could be in a year.

Rochester banking leaders share insights on inflation, interest rates, and local resilience amid 2025 economic and trade policy uncertainty.